03.01.2024 - -Dr. Praveen Tipirneni, returns in full capacity as Chief Executive Officer from medical leave- WALTHAM, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) - Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral .
26.09.2023 - WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) - Morphic Holdings Inc. (Nasdaq: MORF) today announced that Chief Executive Officer Dr. Praveen Tipirneni suffered an emergent medical event and is taking a medical leave of absence. Dr. Tipirneni is .